|
|
| 2019, Vol. 28(6): 401-404 DOI: 10.3760/cma.j.issn.1004-4221.2019.06.001 | ||
| Value of MORC2-IDH1 detection in molecular subtyping of glioblastoma patients treated with postoperative chemoradiotherapy | ||
| Tang Meng, Xu Hui, Wang You, Ding Qianshan, Zhou Fuxiang | ||
| Department of Radiation & Medical Oncology,Zhongnan Hospital of Wuhan University,Clinical CancerStudy Center,Key Laboratory of Tumor Biological Behavior of Hubei Province,Wuhan 430071,China | ||
| Received 2019-03-17 Revised null | ||
| Supporting info | ||
| null | ||
|
